No Matches Found


Loading...
{{stock_short.stock.stock_name.value}}
{{stock_short.stock.price.value}}
{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)
{{ra.field}}
{{ra.stock_return.chgp}}%
{{ra.sensex_return.chgp}}%
{{stock_short.result_details[0].header}}
{{stock_short.result_details[0].latest.to_period}}
{{stock_short.result_details[0].latest.from_period}}
Change%
{{latest.field}}
{{latest.to}}{{latest.value_suffix}}
{{latest.from}}{{latest.value_suffix}}
{{latest.per}}
Figures in Rs cr

When is the next results date for Fervent Synergies Ltd?

The next results date for Fervent Synergies Ltd is February 5, 2026.

Jan 28 2026 11:16 PM IST
share
Share Via

Fervent Synergies Ltd is Rated Strong Sell

Fervent Synergies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Oct 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 19 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Jan 19 2026 10:10 AM IST
share
Share Via
Fervent Synergies Ltd is Rated Strong Sell

Fervent Synergies Ltd is Rated Strong Sell

Fervent Synergies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the latest insights into its performance and outlook.

Jan 06 2026 10:10 AM IST
share
Share Via
Fervent Synergies Ltd is Rated Strong Sell

Fervent Synergies Ltd is Rated Strong Sell

Fervent Synergies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Oct 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 25 December 2025, providing investors with the latest perspective on the company’s position in the market.

Dec 25 2025 03:12 PM IST
share
Share Via
Fervent Synergies Ltd is Rated Strong Sell

Why is Fervent Synerg. falling/rising?

As of 19-Dec, Fervent Synergies Ltd has experienced a modest decline in its share price, continuing a recent downward trend that reflects broader underperformance relative to market benchmarks and waning investor participation.

Dec 20 2025 02:19 AM IST
share
Share Via

Fervent Synergies Falls to 52-Week Low of Rs.17.02 Amid Market Volatility

Shares of Fervent Synergies, a company operating in the Trading & Distributors sector, reached a new 52-week low of Rs.17.02 today, reflecting heightened volatility and a challenging market environment. Despite an intraday high of Rs.20.7, the stock closed near its lowest point, marking a significant price level for investors and market watchers alike.

Dec 08 2025 10:52 AM IST
share
Share Via
Fervent Synergies Falls to 52-Week Low of Rs.17.02 Amid Market Volatility

Fervent Synergies Stock Falls to 52-Week Low of Rs.17.02 Amid Volatility

Fervent Synergies, a company operating in the Trading & Distributors sector, witnessed its stock price touch a fresh 52-week low of Rs.17.02 today, reflecting a notable shift in market dynamics despite an intraday high of Rs.20.7. The stock's performance today was marked by significant volatility, with an intraday price range spanning nearly 10%.

Dec 08 2025 10:52 AM IST
share
Share Via
Fervent Synergies Stock Falls to 52-Week Low of Rs.17.02 Amid Volatility

Fervent Synerg. Sees Revision in Market Evaluation Amidst Challenging Fundamentals

Fervent Synerg., a microcap player in the Trading & Distributors sector, has undergone a notable revision in its market evaluation metrics, reflecting shifts in its fundamental and technical outlook. This adjustment comes amid subdued financial performance and bearish technical signals, underscoring the challenges faced by the company in the current market environment.

Dec 06 2025 10:10 AM IST
share
Share Via
Fervent Synerg. Sees Revision in Market Evaluation Amidst Challenging Fundamentals

Is Fervent Synerg. overvalued or undervalued?

As of December 2, 2025, Fervent Synerg. is fairly valued with a PE ratio of 25.56 and a PEG ratio of 0.22, making it more attractive compared to peers like Sun Pharma and Divi's Lab, despite recent underperformance against the Sensex.

Dec 03 2025 08:10 AM IST
share
Share Via

Why is Fervent Synerg. falling/rising?

As of 14-Nov, Fervent Synergies Ltd's stock price is declining at 21.58, down 3.1%, and has underperformed its sector and the Sensex recently. The stock is trading below all key moving averages, indicating bearish sentiment and reduced investor interest.

Nov 14 2025 10:15 PM IST
share
Share Via

Why is Fervent Synerg. falling/rising?

As of 07-Nov, Fervent Synergies Ltd is currently priced at Rs 23.25, reflecting a 9.98% increase and strong performance compared to its sector and the Sensex. However, a significant decline in investor participation raises concerns about future momentum despite impressive long-term returns.

Nov 07 2025 10:19 PM IST
share
Share Via

Are Fervent Synerg. latest results good or bad?

Fervent Synergies' latest results show significant profit growth and improved margins, but extreme revenue volatility and negative cash flow raise concerns about the sustainability of its operations, suggesting a cautious outlook for the company's future.

Nov 07 2025 07:19 PM IST
share
Share Via

Fervent Synergies Ltd Surges 9.98% Today, Reaching Intraday High of Rs 23.25

Fervent Synergies Ltd is experiencing notable buying activity, with a significant increase in its stock price today. The company has shown strong performance over the past week and year-to-date, outperforming the broader market. Its stock is trading above key moving averages, indicating a robust upward trend.

Nov 07 2025 09:50 AM IST
share
Share Via
Fervent Synergies Ltd Surges 9.98% Today, Reaching Intraday High of Rs 23.25

How has been the historical performance of Fervent Synerg.?

Fervent Synerg. has shown significant revenue growth, with net sales increasing from 0.68 Cr in Mar'22 to 32.46 Cr in Mar'25, and a return to profitability with a profit after tax of 2.95 Cr in Mar'25. However, the company still faces negative cash flow from operating activities at -15.00 Cr in Mar'25.

Nov 06 2025 10:52 PM IST
share
Share Via

Fervent Synergies Q2 FY26: Margin Expansion Masks Revenue Volatility Concerns

Fervent Synergies Ltd., a micro-cap trading and distribution company with a market capitalisation of ₹105.00 crores, reported flat sequential revenue but impressive margin expansion in Q2 FY26. The company posted a net profit of ₹0.43 crores for the quarter ended September 2025, representing a 13.16% quarter-on-quarter increase and a remarkable 975.00% year-on-year surge from the modest ₹0.04 crores reported in the corresponding quarter of the previous year.

Nov 06 2025 07:32 PM IST
share
Share Via
Fervent Synergies Q2 FY26: Margin Expansion Masks Revenue Volatility Concerns

When is the next results date for Fervent Synerg.?

Fervent Synerg. will announce its results on 06 November 2025.

Oct 30 2025 11:22 PM IST
share
Share Via

Why is Fervent Synerg. falling/rising?

As of 28-Oct, Fervent Synergies Ltd's stock price is declining at 20.77, down 3.98% and underperforming its sector. The stock has lost 10.51% over the past week and is trading below all key moving averages, indicating bearish momentum despite a positive year-to-date return.

Oct 29 2025 12:21 AM IST
share
Share Via

Fervent Synergies Faces Technical Shift Amid Declining Sales and Rising Promoter Confidence

Fervent Synergies has recently experienced a change in its evaluation, with technical indicators reflecting a shift in sentiment. Despite a strong annual return of 14.30%, the company faces challenges, including a significant decline in net sales and a low average Return on Equity. Promoter confidence, however, has increased.

Oct 20 2025 08:05 AM IST
share
Share Via
Fervent Synergies Faces Technical Shift Amid Declining Sales and Rising Promoter Confidence

How has been the historical performance of Fervent Synerg.?

Fervent Synerg. has shown significant growth in net sales, increasing from 4.63 Cr in Mar'23 to 32.46 Cr in Mar'25, with a recovery in profitability, achieving an operating profit of 2.99 Cr and positive earnings per share of 0.67 in Mar'25 after previous losses. Total assets and liabilities rose to 48.78 Cr, indicating balanced growth.

Oct 17 2025 10:38 PM IST
share
Share Via

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via
{{list.post_title_sep}}

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
48 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
48 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
48 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
48 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
48 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
48 minutes ago
share
Share Via